null

SMILES: OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F

InChI Key: InChIKey=IENBPQGTFLOJEP-LJQANCHMSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 450238   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	220	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	1.10	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	220	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020)
					More data for this Ligand-Target Pair